Large Scale Culture and Differentiation of Erythroblasts from PBMC and iPSC

外周血单个核细胞 促红细胞生成素 生物 免疫学 细胞生物学 医学 川地34 抗原 红细胞生成 贫血 造血 干细胞 男科 体外 内科学 生物化学
作者
Maria Claessen,Eszter Varga,Steven Heshusius,Esther Heideveld,Martin Hansen,A.S. Visser,Marijke Thiel-Valkhof,Erica Sellink,Patrick Burger,Sacha Zeerleder,Marie José Kersten,Emile van den Akker,Marieke von Lindern
出处
期刊:Blood [American Society of Hematology]
卷期号:132 (Supplement 1): 2319-2319
标识
DOI:10.1182/blood-2018-99-118882
摘要

Abstract Transfusion of donor-derived red blood cells to aleviate anemia is the most common form of cellular therapy. In addition, red blood cells hold great promise as delivery agents of e.g. specific drugs or enzymes. However, the source depends on donor availability and carries a potential risk of alloimmunization and blood borne diseases. More than 30 bloodgroup systems encode >300 bloodgroup antigens and bloodgroup matching becomes increasingly challenging in a multiethnic society. Particularly the chronically transfused patients are at risk for alloimmunisation. In vitro cultured, customizable red blood cells (cRBC) would negate these concerns and introduce precision medicine both in transfusion medicine as well as in drug delivery applications. We aim to produce human cRBC at large-scale and cost effective, for which we need to optimize culture conditions and reduce cost-drivers. We adapted our protocols to GMP culture requirements, which reproducibly provided pure human erythroid cultures within 25 days with a 3.4x107 times expansion from peripheral blood mononuclear cells without prior CD34+ isolation. This expansion depended on the serum free medium we produce, which is supplemented with erythropoietin (Epo, 1 U/ml), stem cell factor (SCF) and glucocorticoids. Expanded erythroblasts CD71 highCD235low/- were differentiated for 10 days in medium supplemented with 5% human plasma, heparin and a higher concentration of Epo (10U/ml) yielding CD71dimCD235a+CD44+CD117-DRAQ5- cRBC. More than 90% of the cells enucleated and expressed adult hemoglobin as well as the correct blood group antigens. Passaging cRBC through a leukodepletion filter yielded 100% enucleated, stable cRBC. Deformability was measured by an Automated Rheoscope and Cell Analyser (ARCA), and oxygen equilibrium curves were measured with a Hemox analyzer. Both parameters were similar in cRBC and freshly isolated reticulocytes. RNA sequencing was performed daily during differentiation and revealed expression dynamics of important erythroid processes, e.g. increased expression of genes involved in blood group expression, globin regulation, and erythroid specific metabolic enzymes, concommittant with loss of expression of genes involved in the formation of organelles, and cell proliferation. The culture process is compatible with upscaling using 5L G-Rex bioreactors., Currently we are preparing a clinical study using biotinylated cRBC. Ultimately, however, large scale production requires an immortal source, for which we aim to use human induced pluripotent stem cells (iPSC) established from rare donors that lack most blood group antigens. Using single cell passaging of iPSC and differentiation in colonies, we generate at average 2x105 cRBC per single iPSC. However, the cRBC cultured from iPSC were less stable following enucleation, and expressed embryonic type globins. Comparison of transcriptome data from iPSC-derived erythroid cells at distinct differentiation stages with erythroid cells at similar stages that were cultured from adult- or cord blood mononuclear cells, or from fetal liver confirmed that most iPSC-derived erythroid cells largely express an embryonic RNA profile. In conclusion, our current protocols enable us to test cRBC cultured from adult peripheral blood for their stability after transfusion. Concurrently, we develop novel bioreactors to upscale the production, and we optimise the protocol to generate cRBC from immortal iPSC lines with near 'universal donor' genotypes. Disclosures No relevant conflicts of interest to declare.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
chichenglin完成签到 ,获得积分10
2秒前
kais完成签到 ,获得积分10
16秒前
谦让月饼完成签到 ,获得积分10
20秒前
zmx完成签到 ,获得积分10
23秒前
每天学习一点点完成签到 ,获得积分10
23秒前
lyp完成签到 ,获得积分10
25秒前
yugongjie完成签到 ,获得积分10
26秒前
满意的雪枫完成签到 ,获得积分10
28秒前
科研通AI2S应助李冲肖采纳,获得10
37秒前
感动尔柳完成签到 ,获得积分20
40秒前
isedu完成签到,获得积分10
40秒前
LT完成签到 ,获得积分10
41秒前
小二郎应助科研通管家采纳,获得10
45秒前
勤恳的TT完成签到 ,获得积分10
47秒前
lizef完成签到 ,获得积分10
50秒前
小粒橙完成签到 ,获得积分10
55秒前
乐正怡完成签到 ,获得积分0
56秒前
yue完成签到,获得积分10
1分钟前
幽默大象完成签到 ,获得积分10
1分钟前
krathhong完成签到 ,获得积分10
1分钟前
粗犷的芝完成签到 ,获得积分20
1分钟前
marceloclaro完成签到,获得积分10
1分钟前
Jessica英语好完成签到 ,获得积分10
1分钟前
loren313完成签到,获得积分0
1分钟前
小小果妈完成签到 ,获得积分10
1分钟前
q1010611084完成签到 ,获得积分10
1分钟前
黄花完成签到 ,获得积分10
1分钟前
纯真的梦竹完成签到,获得积分10
1分钟前
kuyi完成签到 ,获得积分10
2分钟前
e746700020完成签到,获得积分10
2分钟前
fogsea完成签到,获得积分0
2分钟前
是我不得开心妍完成签到 ,获得积分10
2分钟前
Kair完成签到 ,获得积分10
2分钟前
虚幻元风完成签到 ,获得积分10
2分钟前
Hank完成签到 ,获得积分10
2分钟前
崔宁宁完成签到 ,获得积分10
2分钟前
开心夏旋完成签到 ,获得积分10
2分钟前
2分钟前
聪明的行云完成签到 ,获得积分10
2分钟前
郝君颖完成签到 ,获得积分10
2分钟前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052652
求助须知:如何正确求助?哪些是违规求助? 2709863
关于积分的说明 7418267
捐赠科研通 2354446
什么是DOI,文献DOI怎么找? 1246020
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595921